Shinsuke Iida

Shinsuke Iida

UNVERIFIED PROFILE

Are you Shinsuke Iida?   Register this Author

Register author
Shinsuke Iida

Shinsuke Iida

Publications by authors named "Shinsuke Iida"

Are you Shinsuke Iida?   Register this Author

100Publications

2145Reads

47Profile Views

Serum lipidomics for exploring biomarkers of bortezomib therapy in patients with multiple myeloma.

Cancer Sci 2019 Oct 19;110(10):3267-3274. Epub 2019 Sep 19.

Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cas.14178DOI Listing
October 2019

CCR4 is rarely expressed in CCR4-mutated T/NK-cell lymphomas other than adult T-cell leukemia/lymphoma.

Int J Hematol 2019 Oct 29;110(4):389-392. Epub 2019 Aug 29.

Department of Pathology and Molecular Diagnostics, Graduate School of Medical Sciences, Nagoya City University, Nagoya, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12185-019-02728-5DOI Listing
October 2019

[Multiple myeloma: MM].

Authors:
Shinsuke Iida

Rinsho Ketsueki 2019;60(3):251-253

View Article

Download full-text PDF

Source
http://dx.doi.org/10.11406/rinketsu.60.251DOI Listing
August 2019

Impact of chromosomal abnormalities on the efficacy of lenalidomide plus dexamethasone treatment in patients with relapsed/refractory multiple myeloma.

Int J Hematol 2019 Aug 22;110(2):228-236. Epub 2019 May 22.

Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Aichi, 467-8601, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12185-019-02669-zDOI Listing
August 2019

Immunohistochemistry for identification of CCND1, NSD2, and MAF gene rearrangements in plasma cell myeloma.

Cancer Sci 2019 Aug 11;110(8):2600-2606. Epub 2019 Jul 11.

Department of Pathology and Molecular Diagnostics, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cas.14109DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676137PMC
August 2019

Pre- and post-transplant ponatinib for a patient with acute megakaryoblastic blast phase chronic myeloid leukemia with T315I mutation who underwent allogeneic hematopoietic stem cell transplantation.

Int J Hematol 2019 Jul 16;110(1):119-123. Epub 2019 Mar 16.

Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-chou, Mizuho-ku, Nagoya, Aichi, 467-8601, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12185-019-02628-8DOI Listing
July 2019

Mogamulizumab Treatment Elicits Autoantibodies Attacking the Skin in Patients with Adult T-Cell Leukemia-Lymphoma.

Clin Cancer Res 2019 Jul 24;25(14):4388-4399. Epub 2019 Apr 24.

Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Aichi, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-18-2575DOI Listing
July 2019

Expression analysis of two SLAM family receptors, SLAMF2 and SLAMF7, in patients with multiple myeloma.

Int J Hematol 2019 Jul 21;110(1):69-76. Epub 2019 May 21.

Division of Blood Transfusion, Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-chou, Mizuho-ku, Nagoya, Aichi, 467-8601, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12185-019-02649-3DOI Listing
July 2019

JSH practical guidelines for hematological malignancies, 2018: III. Myeloma-2. Related disorders of multiple myeloma.

Int J Hematol 2019 Jun 8;109(6):633-640. Epub 2019 Apr 8.

Department of Hematology, School of Medicine, International University of Health and Welfare, 4-3, Kozunomori, Narita, Chiba, 286-8686, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12185-019-02640-yDOI Listing
June 2019

[Multiple myeloma: update on pathophysiology and management].

Rinsho Ketsueki 2018;59(5):529-538

Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.11406/rinketsu.59.529DOI Listing
May 2019

JSH practical guidelines for hematological malignancies, 2018: III. Myeloma-1. Multiple myeloma (MM).

Int J Hematol 2019 May 4;109(5):509-538. Epub 2019 Apr 4.

Japan Community Health Care Organization Kyoto Kuramaguchi Medical Center, 27 Koyamashimofusa-cho, Kita-ku, Kyoto-shi, Kyoto, 603-8151, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12185-019-02636-8DOI Listing
May 2019

Clinical evaluation of a novel and highly sensitive immunoassay for anti-hepatitis B core antigen using a fully automated immunochemical analyzer.

Hepatol Res 2018 Dec 26;48(13):1081-1091. Epub 2018 Aug 26.

Department of Virology and Liver Unit, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/hepr.13229DOI Listing
December 2018

Weekly carfilzomib and dexamethasone in Japanese patients with relapsed or refractory multiple myeloma: A phase 1 and PK/PD trial.

Cancer Sci 2018 Oct 5;109(10):3245-3252. Epub 2018 Sep 5.

Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cas.13753DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172054PMC
October 2018

Human T-cell lymphotropic/leukemia virus type 1 (HTLV-1) Tax-specific T-cell exhaustion in HTLV-1-infected individuals.

Cancer Sci 2018 Aug 27;109(8):2383-2390. Epub 2018 Jun 27.

Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cas.13654DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6113433PMC
August 2018

CCR4 mutations associated with superior outcome of adult T-cell leukemia/lymphoma under mogamulizumab treatment.

Blood 2018 08 21;132(7):758-761. Epub 2018 Jun 21.

Department of Pathology and Molecular Diagnostics, Graduate School of Medical Sciences, Nagoya City University, Nagoya, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2018-02-835991DOI Listing
August 2018

Improved clonality detection in Hodgkin lymphoma using a semi-nested modification of the BIOMED-2 PCR assay for IGH and IGK rearrangements: A paraffin-embedded tissue study.

Pathol Int 2018 May 25;68(5):287-293. Epub 2018 Mar 25.

Department of Pathology and Molecular Diagnostics, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/pin.12660DOI Listing
May 2018

Cognitive dysfunction among newly diagnosed older patients with hematological malignancy: frequency, clinical indicators and predictors.

Jpn J Clin Oncol 2018 Jan;48(1):61-67

Department of Psychiatry and Cognitive-Behavioral Medicine, Nagoya City University Graduate School of Medical Sciences, Aichi.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyx159DOI Listing
January 2018

Novel monitoring of hepatitis B reactivation based on ultra-high sensitive hepatitis B surface antigen assay.

Liver Int 2017 08 29;37(8):1138-1147. Epub 2017 Jan 29.

Departments of Virology & Liver unit, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/liv.13349
Publisher Site
http://dx.doi.org/10.1111/liv.13349DOI Listing
August 2017

Does cognitive decline decrease health utility value in older adult patients with cancer?

Psychogeriatrics 2017 May 13;17(3):149-154. Epub 2016 Jul 13.

Department of Psychiatry and Cognitive-Behavioral Medicine, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/psyg.12205DOI Listing
May 2017

Elotuzumab with lenalidomide and dexamethasone for Japanese patients with relapsed/refractory multiple myeloma: phase 1 study.

Int J Hematol 2017 03 15;105(3):326-334. Epub 2016 Nov 15.

Department of Internal Medicine, Niigata Cancer Center Hospital, Niigata, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12185-016-2138-4DOI Listing
March 2017

Phase I dose escalation study of high dose carfilzomib monotherapy for Japanese patients with relapsed or refractory multiple myeloma.

Int J Hematol 2016 Nov 26;104(5):596-604. Epub 2016 Jul 26.

Department of Internal Medicine, Niigata Cancer Center Hospital, Niigata, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12185-016-2070-7DOI Listing
November 2016

Quantitative PCR for HTLV-1 provirus in adult T-cell leukemia/lymphoma using paraffin tumor sections.

Pathol Int 2016 Nov 27;66(11):618-621. Epub 2016 Sep 27.

Department of Pathology and Molecular Diagnostics, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/pin.12462DOI Listing
November 2016

[Development of mogamulizumab and establishment of an optimal therapy based on genomic biomarkers: from the academic viewpoint].

Yakugaku Zasshi 2015 ;135(5):663-9

Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences.

View Article

Download full-text PDF

Source
https://www.jstage.jst.go.jp/article/yakushi/135/5/135_14-00
Publisher Site
http://dx.doi.org/10.1248/yakushi.14-00230-3DOI Listing
September 2016

The value of serum Wisteria floribunda agglutinin-positive human Mac-2-binding protein as a predictive marker for hepatitis C virus-related complications after systemic chemotherapy.

Int J Hematol 2016 Sep 2;104(3):384-91. Epub 2016 Jun 2.

Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-chou, Mizuho-ku, Nagoya, Aichi, 467-8601, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12185-016-2033-zDOI Listing
September 2016

Mechanisms of action and resistance for multiple myeloma novel drug treatments.

Authors:
Shinsuke Iida

Int J Hematol 2016 Sep 9;104(3):271-2. Epub 2016 Jun 9.

Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Aichi, 467-8601, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12185-016-2040-0DOI Listing
September 2016

[Multiple Myeloma: from Diagnosis to the Up-to-date Treatment].

Authors:
Shinsuke Iida

Nihon Naika Gakkai Zasshi 2016 Jul;105(7):1199-1201

View Article

Download full-text PDF

Source
July 2016

Medical Decision-Making Incapacity among Newly Diagnosed Older Patients with Hematological Malignancy Receiving First Line Chemotherapy: A Cross-Sectional Study of Patients and Physicians.

PLoS One 2015 21;10(8):e0136163. Epub 2015 Aug 21.

Department of Psychiatry and Cognitive-Behavioral Medicine, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan; Division of Psycho-oncology and Palliative Care, Nagoya City University Hospital, Nagoya, Japan.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0136163PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4546640PMC
May 2016

Design, Synthesis, and Biological Activity of Isosyringolin A.

Org Lett 2016 05 28;18(9):2312-5. Epub 2016 Apr 28.

Faculty of Pharmaceutical Sciences, Hokkaido University , Kita-12, Nishi-6, Kita-ku, Sapporo 060-0812, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.orglett.6b01053DOI Listing
May 2016

Phase I study of once weekly treatment with bortezomib in combination with lenalidomide and dexamethasone for relapsed or refractory multiple myeloma.

Int J Hematol 2016 Mar 29;103(3):316-21. Epub 2015 Dec 29.

Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-chou, Mizuho-ku, Nagoya, Aichi, 467-8601, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12185-015-1925-7DOI Listing
March 2016

Overview: A New Era of Cancer Genomics in Lymphoid Malignancies.

Authors:
Shinsuke Iida

Oncology 2015 10;89 Suppl 1:4-6. Epub 2015 Nov 10.

Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000431056DOI Listing
February 2016

Labial salivary gland biopsy for diagnosing immunoglobulin light chain amyloidosis: a retrospective analysis.

Ann Hematol 2016 Jan 10;95(2):279-85. Epub 2015 Nov 10.

Department of Hematology & Oncology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-chou, Mizuho-ku, Nagoya, 467-8601, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-015-2549-yDOI Listing
January 2016

Fatal reactivation of hepatitis B virus infection in a patient with adult T-cell leukemia-lymphoma receiving the anti-CC chemokine receptor 4 antibody mogamulizumab.

Hepatol Res 2015 Dec 15;45(13):1363-7. Epub 2015 Apr 15.

Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/hepr.12513DOI Listing
December 2015

Screening Performance for Frailty Among Older Patients With Cancer: A Cross-Sectional Observational Study of Two Approaches.

J Natl Compr Canc Netw 2015 Dec;13(12):1525-31

From Division of Psycho-Oncology and Palliative Care, Nagoya City University Hospital, Nagoya, Japan; Department of Psychiatry and Cognitive-Behavioral Medicine, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan; Division of Respiratory Medicine, Juntendo University Faculty of Medicine and Graduate School of Medicine, Tokyo, Japan; and Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan. From Division of Psycho-Oncology and Palliative Care, Nagoya City University Hospital, Nagoya, Japan; Department of Psychiatry and Cognitive-Behavioral Medicine, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan; Division of Respiratory Medicine, Juntendo University Faculty of Medicine and Graduate School of Medicine, Tokyo, Japan; and Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2015.0180DOI Listing
December 2015

Overexpression of salivary-type amylase reduces the sensitivity to bortezomib in multiple myeloma cells.

Int J Hematol 2015 Nov 4;102(5):569-78. Epub 2015 Sep 4.

Division of Hematology, Department of Internal Medicine, Aichi Medical University, 1, 1 Karimata, Yazako, Nagakute, Aichi, 480-1195, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12185-015-1859-0DOI Listing
November 2015

Phase I study of pegylated liposomal doxorubicin in combination with bortezomib for Japanese patients with relapsed or refractory multiple myeloma.

Int J Hematol 2015 Jun 7;101(6):578-84. Epub 2015 Mar 7.

Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s12185-015-1773-5
Publisher Site
http://dx.doi.org/10.1007/s12185-015-1773-5DOI Listing
June 2015

Reactivation of hepatitis B virus (HBV) infection in adult T-cell leukemia-lymphoma patients with resolved HBV infection following systemic chemotherapy.

Int J Hematol 2015 Apr 30;101(4):398-404. Epub 2015 Jan 30.

Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-chou, Mizuho-ku, Nagoya, Aichi, 467-8601, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12185-015-1750-zDOI Listing
April 2015

CD30-positive primary bone marrow lymphoma mimicking Hodgkin lymphoma.

Int J Hematol 2015 Feb 28;101(2):109-11. Epub 2014 Nov 28.

Department of Hematology, Toyokawa City Hospital, 23 Noji, Yawata-cho, Toyokawa, 442-8561, Japan,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12185-014-1714-8DOI Listing
February 2015

[Classification and genetic abnormalities of multiple myeloma].

Nihon Rinsho 2015 Jan;73(1):17-27

View Article

Download full-text PDF

Source
January 2015

Phosphoinositide protein kinase PDPK1 is a crucial cell signaling mediator in multiple myeloma.

Cancer Res 2014 Dec 30;74(24):7418-29. Epub 2014 Sep 30.

Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-14-1420DOI Listing
December 2014

[Multiple Myeloma].

Gan To Kagaku Ryoho 2014 May;41(5):580-6

View Article

Download full-text PDF

Source
May 2014

Design, synthesis, and biological activity of NCC149 derivatives as histone deacetylase 8-selective inhibitors.

ChemMedChem 2014 Mar 8;9(3):657-64. Epub 2014 Jan 8.

Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 13 Taishogun, Nishitakatsukasa-cho, Kita-ku, Kyoto 603-8334 (Japan); PRESTO (Japan) Science and Technology Agency (JST), 4-1-8 Honcho, Kawaguchi, Saitama 332-0012 (Japan).

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cmdc.201300414
Publisher Site
http://dx.doi.org/10.1002/cmdc.201300414DOI Listing
March 2014

[Myeloma therapy (3) Trends in development of new drugs].

Rinsho Ketsueki 2013 Aug;54(8):715-8

View Article

Download full-text PDF

Source
August 2013